# Varex Imaging Corporation (VREX) Stock Analysis: A 50% Potential Upside Drives Investor Enthusiasm

- Link: https://www.directorstalkinterviews.com/varex-imaging-corporation-vrex-stock-analysis-a-50-potential-upside-drives-investor-enthusiasm/4121216601
- Published: 2025-09-18T10:30:37+01:00
- Author: Madison Wilson

Varex Imaging Corporation (NASDAQ: VREX), a key player in the healthcare sector’s
medical devices industry, has captured the attention of investors with its notable
potential upside. With a market capitalization of $481.64 million, the company specializes
in designing, manufacturing, and selling X-ray imaging components, serving both 
medical and industrial applications across the globe.

Currently trading at $11.60 per share, Varex presents a compelling opportunity for
investors, especially considering the consensus target price of $17.40, representing
a potential upside of 50%. This optimistic outlook is supported by four “Buy” ratings
out of the total analyst coverage, with no “Sell” ratings, indicating confidence
in the company’s future prospects.

Varex operates through two primary segments: Medical and Industrial. The Medical
segment offers a wide array of X-ray imaging components utilized in various diagnostic
applications such as CT, mammography, and oncology. Meanwhile, the Industrial segment
focuses on security and inspection applications, including airport baggage screening
and cargo inspection at borders, showcasing the company’s versatile portfolio.

Examining Varex’s valuation metrics reveals some challenges, notably the absence
of a trailing P/E ratio and negative earnings per share (EPS) of -3.23. The forward
P/E ratio stands at 14.64, suggesting that while current earnings are negative, 
analysts expect profitability in the coming periods. This expectation is critical
for investors who look beyond present challenges towards future earnings potential.

The company’s recent financial performance has been mixed, with a revenue decline
of 2.90%. Additionally, key performance indicators such as return on equity (-24.79%)
and free cash flow (-$4.1 million) highlight areas needing improvement. These figures
underscore the necessity for strategic initiatives to bolster financial health and
operational efficiency.

Technical indicators provide an interesting perspective on Varex’s recent stock 
performance. The stock’s 50-day moving average is at $9.64, while the 200-day moving
average is $10.88, signaling a positive short-term trend. The Relative Strength 
Index (RSI) of 53.26 suggests that the stock is neither overbought nor oversold,
indicating relative stability in recent trading activity.

Varex’s extensive geographic footprint, including operations in North America, Europe,
and Asia, positions it favorably to leverage diverse market opportunities. The company’s
broad reach and comprehensive product lineup make it a formidable player in the 
X-ray imaging sector, poised for growth as global demand for advanced medical imaging
solutions continues to rise.

Despite the lack of a dividend yield, which might deter income-focused investors,
Varex’s potential for capital appreciation due to its growth prospects and strategic
positioning could attract those looking for long-term gains. The company’s focus
on innovation and expanding its market presence could be pivotal in achieving sustained
revenue growth and improving profitability.

In essence, Varex Imaging Corporation presents a nuanced investment case. While 
current financial metrics may pose concerns, the significant potential upside and
analyst confidence provide compelling reasons for investors to consider adding VREX
to their portfolios. As the company navigates its financial and operational challenges,
its strategic initiatives and market opportunities could unlock substantial value
for shareholders.

Share on:
